DR. HOWARD MARTIN FILLIT, MD
Osteopathic Medicine at 60 St, New York, NY
License number
New York 125522
Category
Osteopathic Medicine
Type
Geriatric Medicine
Address
Address
2
121 E 60Th St, New York, NY 10022
33 Victoria Ln, Tenafly, NJ 07670
33 Victoria Ln, Tenafly, NJ 07670
Phone
(212) 758-4633
(201) 819-1920
(201) 819-1920
Personal information
See more information about HOWARD MARTIN FILLIT at radaris.comName
Address
Phone
300 E 56Th St APT 31A, New York, NY 10022
Englewood, NJ
121 60Th St, New York, NY 10022
931 State St, Syracuse, NY 13208
33 Victoria Ln, Tenafly, NJ 07670
Professional information
Executive Director At Alzheimer's Drug Discovery Foundation Clinical Professor Of Geriatrics And Medicine, Professor Of Neurobiology At Mount Sinai School Of Medicine Resume At Alzheimer's Drug Discovery Foundation See Less...
Location:
Greater New York City Area
Industry:
Philanthropy
Experience:
Alzheimer's Drug Discovery Foundation (Non-Profit; Philanthropy industry): Executive Director, (1998-Present) Accelerating drug discovery for Alzheimer's disease through venture philanthropyMount Sinai School of Medicine (Educational Institution; 5001-10,000 employees...
Howard Martin Fillit, New York NY
Specialties:
Geriatrician
Address:
121 E 60Th St, New York, NY 10022
Education:
State University of New York, Upstate Medical University - Doctor of Medicine
New York Presbyterian Hospital/Weill Cornell Medical Center - Fellowship - Nephrology (Internal Medicine)
New York Presbyterian Hospital/Weill Cornell Medical Center - Fellowship - Nephrology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Geriatric Medicine (Internal Medicine)
Test For The Detection Of Anti-Heparin Antibodies
US Patent:
5753445, May 19, 1998
Filed:
Apr 26, 1994
Appl. No.:
8/233390
Inventors:
Howard M. Fillit - Tenafly NJ
Peter C. Harpel - New York NY
Peter C. Harpel - New York NY
Assignee:
The Mount Sinai Medical Center of the City University of New York - New York NY
International Classification:
G01N 3353
US Classification:
435 71
Abstract:
This invention pertains to a method of detecting, in a sample obtained from an individual, anti-heparin antibodies which inhibit the formation of the heparin accelerated antithrombin III-thrombin complex. In the present method, the presence of such anti-heparin antibodies are detected directly (by detecting the presence of anti-heparin antibodies themselves) or indirectly (by detecting the presence or formation of the heparin accelerated antithrombin III-thrombin complex). In one embodiment of the present method, antibodies which react with or interfere with the heparin pentasaccharide which binds antithrombin III in such a manner that binding to antithrombin III is inhibited are detected. In a specific embodiment of the present method, the anti-heparin antibody detected is one which reacts with or interferes with the disaccharide UA-2S/GlcNs-6 present in residues IV and V of the heparin pentasaccharide that binds antithrombin III.
Kit For The Determination And Diagnosis Of Non-Goodpasture Glomerulonephritis
US Patent:
4985542, Jan 15, 1991
Filed:
May 17, 1989
Appl. No.:
7/352727
Inventors:
Howard Fillit - New York NY
Shridhar P. Damle - New York NY
John Zabriskie - New York NY
John D. Gregory - New York NY
Shridhar P. Damle - New York NY
John Zabriskie - New York NY
John D. Gregory - New York NY
Assignee:
The Rockefeller University - New York NY
International Classification:
C07K 1514, C07K 300, A61K 3900, A61K 3512
US Classification:
530395
Abstract:
Purified glomerular proteoglycans are used as a basis for a diagnostic test for glomerulonephritis in humans involving an immunological reaction between the purified proteoglycans and patient area. A new method for purification of glomeruli proteoglycan antigens is described using guanidine extraction.
Method For Determination And Diagnosis Of Non-Goodposture Glomerulonephritis
US Patent:
4849339, Jul 18, 1989
Filed:
Jun 8, 1984
Appl. No.:
6/618500
Inventors:
Howard Fillit - New York NY
Shridhar P. Damle - New York NY
John Zabriskie - New York NY
John D. Gregory - New York NY
Shridhar P. Damle - New York NY
John Zabriskie - New York NY
John D. Gregory - New York NY
Assignee:
Rockefeller University - New York NY
International Classification:
G01N 33535
US Classification:
435 7
Abstract:
Purified glomerular proteoglycans are used as a basis for a diagnostic test for glomerulonephritis in humans involving an immunological reaction between the purified proteoglycans and patient sera. A new method for purification of glomeruli proteoglycan antigens is described using guanidine extraction.